AstraZeneca Under Scrutiny Again as Countries Spend Billions Purchasing Its Low-Cost Vaccine

The Most Revolutionary Act

By  Jeremy Loffredo

Another AstraZeneca vaccine trial participant alleges serious injury, but the vaccine is still a favorite with the Gates Foundation and developing countries.

AstraZeneca’s COVID vaccine faced new controversy this week after a trial participant in India alleged that the vaccine caused him serious “neurological and psychological” symptoms.

The accusation was the latest in a series of complaints or concerns surrounding Covishield, the AstraZeneca vaccine being developed in partnership with Oxford University.

Yet despite concerns about safety and trial design, countries are already spendingbillions of dollars in taxpayer funds to purchase AstraZeneca’s vaccine, in part because, compared with frontrunners Moderna and Pfizer, AstraZeneca’s vaccine is easier to store and faster to distribute.

The latest news also hasn’t changed plans by the Global Alliance for Vaccine Initiative (GAVI), a public-private partnership founded by the Bill & Melinda Gates Foundation, to distribute the AstraZeneca COVID vaccine globally, once…

View original post 493 more words

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: